CLAIBORNE CARY J enters NEUROSENSE THERAPEUTICS LTD. with 207.90K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030600
Director
Since Mar 2026
207.90K
Baseline shares
100% direct
207.90K
Direct ownership
3 positions
72K
Derivative underlying
1 instrument
3
Security positions
All direct
Non-Derivative Holdings3
Ordinary Shares
DirectShares owned48K
Ordinary Shares
DirectShares owned99.90K
Ordinary Shares
DirectShares owned60K
Total
207.90K direct207.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 48K | Direct |
| Ordinary Shares | 99.90K | Direct |
| Ordinary Shares | 60K | Direct |
| Total | 207.90K | 207.90K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
72K
Shares owned
N/A
Exercise price
1.43
Expiration
—
Exercise window
—
Total
Underlying
72K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 1.43 | — | — | 72K | N/A |
| Total | 72K | 0.00 | ||||